GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verastem Inc (FRA:2VSA) » Definitions » Purchase Of Investment

Verastem (FRA:2VSA) Purchase Of Investment : €-77.19 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Verastem Purchase Of Investment?

Verastem's purchase of investment for the three months ended in Mar. 2024 was €0.00 Mil. It means Verastem spent €0.00 Mil on purchasing investments. Verastem's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €-77.19 Mil.

Compared with last quarter (€-11.52 Mil in Dec. 2023 ), Verastem spent less money on purchasing investments in Mar. 2024 (€0.00 Mil).


Verastem Purchase Of Investment Historical Data

The historical data trend for Verastem's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verastem Purchase Of Investment Chart

Verastem Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -84.71 -65.25 -76.50 -16.82 -88.44

Verastem Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.89 - -65.66 -11.52 -

Verastem Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-77.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verastem Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Verastem's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Verastem (FRA:2VSA) Business Description

Traded in Other Exchanges
Address
117 Kendrick Street, Suite 500, Needham, MA, USA, 02494
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Verastem (FRA:2VSA) Headlines

No Headlines